Jakarta, CNBC Indonesia – In 2020 it can be said that it is not a good year for the stock market, as well as for the Indonesian and global economies.
Post-virus attack Covid-19, the global capital market, especially the Indonesian capital market, has not been able to recover to its level at the beginning of the year and is still correcting quite badly.
This can be shown from the local reference index, namely the Composite Stock Price Index (IHSG) which is still corrected for the current year 18.99%.
Even though the average share price is corrected, of course not allstock price affected by the virus nCov-19 equally.
But in the midst of the JCI’s fall, some stocks have recovered from the attack of the corona virus, even a handful of stocks managed to triumph amid the outbreak of this crowd-loving virus.
Which stocks managed to bring how big during 2020?
10 Shares with Biggest Gain 2020, Jan-16 Oct
In first place is the banking issuer PT Bank Jago Tbk (ARTO). The digital bank reportedly backed by Gojek was successful 481% share during the year (YTD).
The bank, formerly known as PT Bank Artos Indonesia Tbk, was once owned by the Arto Hardy family which was later taken over by Northstar boss Patrick Walujo and former BTPN banker Jerry Ng last year.
Meanwhile, in second place is the pharmaceutical issuer PT Pyridam Farma Tbk (PYFA) which has successfully appreciated 364% year to date.
This increase was after market participants responded to the news that PT Pyridam Internasional has beenswitch the status as wantwhether PYFA kepada Rejuve Global Investment Pte Ltd.
Pyridam Farma Corporate Secretary Ryan Arvin Sutikno reported that Pyridam International (PYI), Rejuve Global Investment (RGI), and PT Starindo Kencana Sejahtera (SKS) had completed the transaction or closed the sale and purchase of shares in Pyridam Farma (PYFA).
In the third position, there are shares of PT Bank BRISyariah Tbk (BRIS), which was previously reported to be undergoing a merger with other Islamic state-owned banks so that investors bought it, causing BRIS’s shares to fly 322%.
BRIS itself is the only public company among the three Islamic state-owned banks to be merged.
Three Islamic commercial banks are state-owned subsidiaries, namely PT Bank BNI Syariah, PT Bank Rakyat Indonesia Syariah, and PT Bank Syariah Mandiri I haveofficially underwent a merger process.
This is stated in an MoU or Memorandum of Understanding [Conditional Merger Agreement] between the three banks and their respective parent companies.
BRIS was determined to be a survivor bank or entity that received the merger (surviving entity) from the merger of three BUMN sharia banks.
“Paying attention to the Conditional Merger Agreement, after the merger becomes effective, BRIS will become the entity that receives the merger, and the shareholders of BNI Syariah and the shareholders of BSM, will be the shareholders of the entity that accepts the merger,” wrote BRIS management in an information disclosure, quoted on Tuesday (13 / 10/2020).
In fourth and fifth positions are Bio Farma’s subsidiaries, PT Indofarma Tbk (INAF) and PT Kimia Farma Tbk (KAEF), which respectively managed to rally by 289% and 167% this year.
The rise in INAF shares came after vaccine sentiment led investors to buy up pharmaceutical stocks
Previously it was reported that the Sinovac vaccine had arrived in Indonesia and a subsidiary of Bio Farma would later collaborate and become a distributor of the vaccine.
In composition there are 4 stocks from the financial sector, namely ARTO, BRIS, PT Bank BRI Agroniaga Tbk (AGRO), PT KDB Tifa Finance Tbk (TIFA).
Middle and lower class banking stocks are indeed being traded attractively, because recently they have been angry with corporate actions such as acquisitions or mergers in this sector.
In addition to the three financial sector stocks that will carry out the corporate actions discussed above, TIFA financing issuers also managed to jump 114% after being officially annexed by the Korean Development Bank (KDB) from South Korea.
Furthermore, there are 3 stocks from the pharmaceutical sector namely PYFA, INAF, and KAEF. The pharmaceutical sector has benefited from the presence of the corona virus. Investors are betting that the distribution of the corona vaccine will benefit these pharmaceutical companies.
RESEARCH TEAM CNBC INDONESIA
(bag bag)
– .
